Process optimization of a complex pharmaceutical polymorphic system via in situ Raman spectroscopy

被引:83
作者
Starbuck, C [1 ]
Spartalis, A [1 ]
Wai, L [1 ]
Wang, J [1 ]
Fernandez, P [1 ]
Lindemann, CM [1 ]
Zhou, GX [1 ]
Ge, ZH [1 ]
机构
[1] Merck Res Labs, Proc Res & Dev, Rahway, NJ 07065 USA
关键词
D O I
10.1021/cg025559k
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In situ Raman spectroscopy was used to determine the rate of polymorph turnover for MK-A, a multipolymorphic compound in development at Merck Research Laboratories. The known crystal forms of MK-A include four anhydrous polymorphs, two hydrates, and numerous solvates. The penultimate and pure steps of this process involve a coupling reaction to generate a mixture of crystal forms followed by turnover to the desired polymorph, form A. This paper summarizes experiments to measure the kinetics of polymorph turnover from all relevant MK-A crystal forms to form A. Additionally, the turnover kinetics for polymorph reversion from form A to undesired forms were measured under simulated process upset conditions. The use of thermodynamic data to establish process boundaries and kinetic data to establish process time cycles resulted in the, definition of a highly robust, cycle time efficient slurry turnover process to produce form A from any combination of other MK-A crystal forms.
引用
收藏
页码:515 / 522
页数:8
相关论文
共 19 条
[1]   Near-IR detection of polymorphism and process-related substances [J].
Aldridge, PK ;
Evans, CL ;
Ward, HW ;
Colgan, ST ;
Boyer, N ;
Gemperline, PJ .
ANALYTICAL CHEMISTRY, 1996, 68 (06) :997-1002
[2]  
Barrett P, 1999, PART PART SYST CHAR, V16, P207, DOI 10.1002/(SICI)1521-4117(199910)16:5<207::AID-PPSC207>3.0.CO
[3]  
2-U
[4]   PHARMACEUTICAL SOLIDS - A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS [J].
BYRN, S ;
PFEIFFER, R ;
GANEY, M ;
HOIBERG, C ;
POOCHIKIAN, G .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :945-954
[5]   Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development [J].
Chemburkar, SR ;
Bauer, J ;
Deming, K ;
Spiwek, H ;
Patel, K ;
Morris, J ;
Henry, R ;
Spanton, S ;
Dziki, W ;
Porter, W ;
Quick, J ;
Bauer, P ;
Donaubauer, J ;
Narayanan, BA ;
Soldani, M ;
Riley, D ;
McFarland, K .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2000, 4 (05) :413-417
[6]   Polymorphism in molecular crystals: Stabilization of a metastable form by conformational mimicry [J].
Davey, RJ ;
Blagden, N ;
Potts, GD ;
Docherty, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (07) :1767-1772
[7]  
Garner W.E., 1955, CHEM SOLID STATE
[8]  
GRANT DJW, 1999, POLYMORPHISM PHARM S
[9]   Polymorph screening: Influence of solvents on the rate of solvent-mediated polymorphic transformation [J].
Gu, CH ;
Young, V ;
Grant, DJW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (11) :1878-1890
[10]   PHARMACEUTICAL HYDRATES [J].
KHANKARI, RK ;
GRANT, DJW .
THERMOCHIMICA ACTA, 1995, 248 :61-79